Immune and endothelial activation markers and risk stratification of childhood pneumonia in Uganda: A secondary analysis of a prospective cohort study

Background Despite the global burden of pneumonia, reliable triage tools to identify children in low-resource settings at risk of severe and fatal respiratory tract infection are lacking. This study assessed the ability of circulating host markers of immune and endothelial activation quantified at presentation, relative to currently used clinical measures of disease severity, to identify children with pneumonia who are at risk of death. Methods and findings We conducted a secondary analysis of a prospective cohort study of children aged 2 to 59 months presenting to the Jinja Regional Hospital in Jinja, Uganda between February 2012 and August 2013, who met the Integrated Management of Childhood Illness (IMCI) diagnostic criteria for pneumonia. Circulating plasma markers of immune (IL-6, IL-8, CXCL-10/IP-10, CHI3L1, sTNFR1, and sTREM-1) and endothelial (sVCAM-1, sICAM-1, Angpt-1, Angpt-2, and sFlt-1) activation measured at hospital presentation were compared to lactate, respiratory rate, oxygen saturation, procalcitonin (PCT), and C-reactive protein (CRP) with a primary outcome of predicting 48-hour mortality. Of 805 children with IMCI pneumonia, 616 had severe pneumonia. Compared to 10 other immune and endothelial activation markers, sTREM-1 levels at presentation had the best predictive accuracy in identifying 48-hour mortality for children with pneumonia (AUROC 0.885, 95% CI 0.841 to 0.928; p = 0.03 to p < 0.001) and severe pneumonia (AUROC 0.870, 95% CI 0.824 to 0.916; p = 0.04 to p < 0.001). sTREM-1 was more strongly associated with 48-hour mortality than lactate (AUROC 0.745, 95% CI 0.664 to 0.826; p < 0.001), respiratory rate (AUROC 0.615, 95% CI 0.528 to 0.702; p < 0.001), oxygen saturation (AUROC 0.685, 95% CI 0.594 to 0.776; p = 0.002), PCT (AUROC 0.650, 95% CI 0.566 to 0.734; p < 0.001), and CRP (AUROC 0.562, 95% CI 0.472 to 0.653; p < 0.001) in cases of pneumonia and severe pneumonia. The main limitation of this study was the unavailability of radiographic imaging. Conclusions In this cohort of Ugandan children, sTREM-1 measured at hospital presentation was a significantly better indicator of 48-hour mortality risk than other common approaches to risk stratify children with pneumonia. Measuring sTREM-1 at clinical presentation may improve the early triage, management, and outcome of children with pneumonia at risk of death. Trial registration The trial was registered at clinicaltrial.gov (NCT 04726826).

[1]  K. Kain,et al.  COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department , 2020, Journal of Allergy and Clinical Immunology.

[2]  K. Kain,et al.  Risk-stratification of febrile African children at risk of sepsis using sTREM-1 as basis for a rapid triage test , 2020, Nature Communications.

[3]  J. van Griensven,et al.  Point-of-Care Biomarkers to Guide Antibiotic Prescription for Acute Febrile Illness in Sub-Saharan Africa: Promises and Caveats , 2020, Open forum infectious diseases.

[4]  N. Kissoon,et al.  Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children , 2020, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[5]  K. Kain,et al.  Prognostic accuracy of sTREM-1-based algorithms in febrile adults presenting to Tanzanian outpatient clinics. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  E. Launay,et al.  Antibiotic prescription in paediatric emergency departments: fear and reason. , 2019, The Lancet. Infectious diseases.

[7]  O. Sibila,et al.  Biomarkers in community-acquired pneumonia: still searching for the one , 2019, European Respiratory Journal.

[8]  R. Schmicker,et al.  Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months , 2018, JAMA pediatrics.

[9]  Amy Sarah Ginsburg,et al.  A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia , 2018, American journal of respiratory and critical care medicine.

[10]  K. Kain,et al.  Endothelial Activation: The Ang/Tie Axis in Sepsis , 2018, Front. Immunol..

[11]  M. Matthay,et al.  Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS , 2018, Pulmonary circulation.

[12]  P. Vanhems,et al.  Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study , 2017, The American journal of tropical medicine and hygiene.

[13]  K. Kain,et al.  Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection , 2017, PloS one.

[14]  L. Purcell,et al.  Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria , 2016, Science Translational Medicine.

[15]  D. Christiani,et al.  Gene control of tyrosine kinase TIE2 and vascular manifestations of infections , 2016, Proceedings of the National Academy of Sciences.

[16]  J. Mesirov,et al.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia. , 2016, American journal of respiratory and critical care medicine.

[17]  M. Wurfel,et al.  Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness , 2015, PloS one.

[18]  B. Genton,et al.  Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. , 2015, The Lancet. Infectious diseases.

[19]  K. Kain,et al.  Prospective validation of pediatric disease severity scores to predict mortality in Ugandan children presenting with malaria and non-malaria febrile illness , 2015, Critical Care.

[20]  Jamie Perin,et al.  Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis , 2015, The Lancet.

[21]  S. Gibot,et al.  Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? , 2014, Front. Microbiol..

[22]  K. Kain,et al.  Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case–control study of African children , 2014, Malaria Journal.

[23]  M. Colonna,et al.  Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1)-mediated Bcl-2 Induction Prolongs Macrophage Survival* , 2014, The Journal of Biological Chemistry.

[24]  Valérie D'Acremont,et al.  Beyond malaria--causes of fever in outpatient Tanzanian children. , 2014, The New England journal of medicine.

[25]  Q. Shu,et al.  Activation of Triggering Receptor Expressed on Myeloid Cells-1 Protects Monocyte from Apoptosis through Regulation of Myeloid Cell Leukemia-1 , 2013, Anesthesiology.

[26]  W. Liles,et al.  Biomarkers of endothelial activation/dysfunction in infectious diseases , 2013, Virulence.

[27]  W. Liles,et al.  Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review , 2012, Critical Care.

[28]  K. Kain,et al.  Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics , 2011, Current opinion in hematology.

[29]  W. Liles,et al.  Endothelial activation, dysfunction and permeability during severe infections , 2011, Current opinion in hematology.

[30]  K. Kain,et al.  Systemic dysregulation of angiopoietin-1/2 in streptococcal toxic shock syndrome. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  H. Wong,et al.  Biomarkers for pediatric sepsis and septic shock , 2011, Expert review of anti-infective therapy.

[32]  M. Leach,et al.  Access to health care and mortality of children under 5 years of age in the Gambia: a case-control study. , 2009, Bulletin of the World Health Organization.

[33]  Igor Rudan,et al.  Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.

[34]  M. Colonna,et al.  The TREM receptor family and signal integration , 2006, Nature Immunology.

[35]  D. Kwiatkowski,et al.  Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[36]  Elizabeth Molyneux,et al.  Improved triage and emergency care for children reduces inpatient mortality in a resource-constrained setting. , 2006, Bulletin of the World Health Organization.

[37]  H. Rammensee,et al.  Triggering Receptor Expressed on Myeloid Cells-1 in Neutrophil Inflammatory Responses: Differential Regulation of Activation and Survival , 2004, The Journal of Immunology.

[38]  L. Muhe,et al.  Quality of hospital care for seriously ill children in less-developed countries , 2001, The Lancet.

[39]  H. Davies,et al.  Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children. , 1996, The Pediatric infectious disease journal.